The performance of companies tied to blockbuster drugs like Viagra presents a nuanced investment scenario . While the initial boom of copyright, fueled by Viagra's remarkable popularity, generated substantial profits , the loss of exclusivity in key markets has introduced considerable risk . Investors are now assessing the consequences of generic c